Global Peptide Synthesis Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Peptide Synthesis Market is presumed to reach the market size of nearly USD 2263.9 Million by 2032 from USD 690.69 Million in 2023 with a CAGR of 14.1% under the study period 2024 - 2032.

Peptides possess broad range of biological functions such as anti-oxidant properties, hormonal functions, antimicrobial agents, clinical diagnosis, and also act as growth factors. Furthermore, they are also used in drug development as potential active pharmaceutical ingredients owing to their high specificity, large chemical space, ease of synthesis, biological activity, low toxicity, and ready availability. They are also exploited in the treatment of several diseases including cardiovascular diseases, cancer, respiratory disorders, and others. Peptide molecules gained immense momentum in nutrition and healthcare industries attributed to the various technological advancements in the peptide production. For instance, chemical synthesis is considered as the traditional and widely used technology for peptide synthesis; however, the process lacked specificity and increased the risk of environmental burdens. Therefore, this caused the adoption of enzymatic technology for peptide synthesis.

Market Dynamics

Escalating usage of peptides in the production of pharmaceutical drugs propels the market growth. Peptides are highly specific and active drugs with diverse biological functions that are used in a broad range of therapeutic areas. Diabetes, oncology, and obesity are the three major therapeutic areas in which peptides generate profits in billions of dollars. According to the research study by National Cancer Institute, 1,735,350 cancer cases were diagnosed in the U.S in 2018. Additionally, owing to the growing sedentary lifestyle among populace increases the chances of obesity. Therefore, rising disease conditions boost the growth of global peptide synthesis market. Moreover, the increase in research & development activities in the peptide synthesis market also contributes to the market growth. The rising participation of research entities and investment for the advanced and innovative bio-based products in order to overcome the global health challenges positively influences the market growth. However, contamination issues during the course of peptide synthesis coupled with lack of upgradation in regulatory standards acts as a restrain for the market progression. Various companies are developing advanced technologies for peptide production, and it is anticipated to create lucrative opportunities for the market in the coming years. For example, New England Peptide Inc. uses a unique software program named Pep Trend system, to design and produce custom peptides.

The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each application/product segment in the global market of peptide synthesis.

Market Segmentation

The entire peptide synthesis market has been sub-categorized into product, application, technology and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.

By Product

Equipment (Peptide Synthesizers, Lyophilizers, Chromatography Equipment, Others)
Reagents & Consumables
Other

By Technology

Solid Phase Peptide Synthesis (SPPS)
Liquid Phase Peptide Synthesis (LPPS)
Hybrid Technology

By Application

Therapeutics (Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT (Gastrointestinal Disorders), Infectious Diseases, Pain, Dermatology, CNS, Renal, Others)
Diagnosis
Research

By End-use

Pharmaceutical & Biotechnology Companies
Contract Development & Manufacturing Organization/Contract Research Organization
Academic & Research Institutes
Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for peptide synthesis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the peptide synthesis market include Genscript Biotech, Merck KGaA, Bachem Holdings, Biotage, CEM Corporation, Thermo Fisher, Creative Diagnostics, Polypeptide Group, Syngene, PuroSynth, Lonza, MP Biomedicals and Novo Nordisk A/S. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11211390

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. PEPTIDE SYNTHESIS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By End-use
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL PEPTIDE SYNTHESIS MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data
5.3. Analysis By Product
5.4. Equipment (Peptide Synthesizers, Lyophilizers, Chromatography Equipment, Others) Historic and Forecast Sales By Regions
5.5. Reagents & Consumables Historic and Forecast Sales By Regions
5.6. Other Historic and Forecast Sales By Regions

6. GLOBAL PEPTIDE SYNTHESIS MARKET ANALYSIS BY TECHNOLOGY

6.1. Overview By Technology
6.2. Historical and Forecast Data
6.3. Analysis By Technology
6.4. Solid Phase Peptide Synthesis (SPPS) Historic and Forecast Sales By Regions
6.5. Liquid Phase Peptide Synthesis (LPPS) Historic and Forecast Sales By Regions
6.6. Hybrid Technology Historic and Forecast Sales By Regions

7. GLOBAL PEPTIDE SYNTHESIS MARKET ANALYSIS BY APPLICATION

7.1. Overview By Application
7.2. Historical and Forecast Data
7.3. Analysis By Application
7.4. Therapeutics (Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT (Gastrointestinal Disorders), Infectious Diseases, Pain, Dermatology, CNS, Renal, Others) Historic and Forecast Sales By Regions
7.5. Diagnosis Historic and Forecast Sales By Regions
7.6. Research Historic and Forecast Sales By Regions

8. GLOBAL PEPTIDE SYNTHESIS MARKET ANALYSIS BY END-USE

8.1. Overview By End-use
8.2. Historical and Forecast Data
8.3. Analysis By End-use
8.4. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
8.5. Contract Development & Manufacturing Organization/Contract Research Organization Historic and Forecast Sales By Regions
8.6. Academic & Research Institutes Historic and Forecast Sales By Regions

9. GLOBAL PEPTIDE SYNTHESIS MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE PEPTIDE SYNTHESIS COMPANIES

10.1. Peptide Synthesis Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF PEPTIDE SYNTHESIS INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Genscript Biotech
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Merck KGaA
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Bachem Holdings
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Biotage
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. CEM Corporation
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Thermo Fisher
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Creative Diagnostics
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Polypeptide Group
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Syngene
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. PuroSynth
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Lonza
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments
11.14. MP Biomedicals And Novo Nordisk A/S.
- 11.14.1 Company Overview
- 11.14.2 Company Revenue
- 11.14.3 Products
- 11.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies